Microvascular disease in diabetes and severe COVID-19 outcomes

Lancet Diabetes Endocrinol. 2021 Apr;9(4):200-201. doi: 10.1016/S2213-8587(21)00053-X.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • COVID-19*
  • Cohort Studies
  • Diabetes Mellitus*
  • Humans
  • Risk Factors
  • SARS-CoV-2
  • Scotland